| Primary |
| Depression |
54.7% |
| Anxiety |
9.9% |
| Product Used For Unknown Indication |
6.7% |
| Hypertension |
4.2% |
| Major Depression |
3.6% |
| Pain |
2.5% |
| Drug Use For Unknown Indication |
2.4% |
| Schizophrenia |
1.8% |
| Sleep Disorder |
1.8% |
| Bipolar Disorder |
1.7% |
| Post-traumatic Stress Disorder |
1.3% |
| Anxiety Disorder |
1.3% |
| Hot Flush |
1.2% |
| Psychotic Disorder |
1.2% |
| Panic Disorder |
1.1% |
| Schizoaffective Disorder |
1.1% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Drug Exposure During Pregnancy |
0.9% |
| Convulsion |
0.8% |
| Hypothyroidism |
0.8% |
|
| Drug Ineffective |
25.9% |
| Completed Suicide |
8.4% |
| Vomiting |
6.5% |
| Suicide Attempt |
6.1% |
| Tachycardia |
5.4% |
| Depression |
5.2% |
| Drug Interaction |
3.6% |
| Serotonin Syndrome |
3.5% |
| Suicidal Ideation |
3.5% |
| Tremor |
3.5% |
| Withdrawal Syndrome |
3.3% |
| Death |
3.1% |
| Malaise |
3.1% |
| Somnolence |
3.1% |
| Anxiety |
2.7% |
| Hyponatraemia |
2.7% |
| Nausea |
2.7% |
| Product Substitution Issue |
2.7% |
| Respiratory Arrest |
2.7% |
| Headache |
2.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
32.9% |
| Depression |
25.3% |
| Product Used For Unknown Indication |
10.7% |
| Anxiety |
8.0% |
| Hypertension |
2.9% |
| Major Depression |
2.7% |
| Bipolar Disorder |
2.7% |
| Pain |
2.1% |
| Sleep Disorder |
1.5% |
| Psychotic Disorder |
1.4% |
| Bipolar I Disorder |
1.3% |
| Suicide Attempt |
1.3% |
| Ill-defined Disorder |
1.2% |
| Insomnia |
1.1% |
| Completed Suicide |
0.9% |
| Intentional Overdose |
0.8% |
| Diabetes Mellitus |
0.8% |
| Post-traumatic Stress Disorder |
0.8% |
| Hot Flush |
0.8% |
| Panic Attack |
0.8% |
|
| Completed Suicide |
22.8% |
| Respiratory Arrest |
8.8% |
| Drug Ineffective |
7.2% |
| Death |
6.4% |
| Suicide Attempt |
5.7% |
| Tremor |
4.9% |
| Drug Toxicity |
4.6% |
| Tachycardia |
3.8% |
| Suicidal Ideation |
3.7% |
| Vomiting |
3.7% |
| Poisoning |
3.4% |
| Serotonin Syndrome |
3.4% |
| Cardio-respiratory Arrest |
3.3% |
| Depression |
3.1% |
| Anxiety |
2.8% |
| Overdose |
2.8% |
| Withdrawal Syndrome |
2.8% |
| Weight Increased |
2.5% |
| Nausea |
2.1% |
| Somnolence |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.0% |
| Depression |
16.8% |
| Product Used For Unknown Indication |
10.4% |
| Hypertension |
5.2% |
| Rheumatoid Arthritis |
5.1% |
| Pain |
5.1% |
| Anxiety |
4.0% |
| Bipolar Disorder |
2.6% |
| Crohn's Disease |
2.4% |
| Schizophrenia |
2.1% |
| Prophylaxis |
1.8% |
| Insomnia |
1.7% |
| Hiv Infection |
1.7% |
| Multiple Sclerosis |
1.6% |
| Diabetes Mellitus |
1.4% |
| Psychotic Disorder |
1.3% |
| Psoriasis |
1.3% |
| Hepatitis C |
1.3% |
| Asthma |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Vomiting |
12.3% |
| Weight Decreased |
10.9% |
| Weight Increased |
10.1% |
| Withdrawal Syndrome |
8.0% |
| Tremor |
5.8% |
| Suicide Attempt |
4.6% |
| Drug Interaction |
4.4% |
| Overdose |
4.4% |
| Death |
4.2% |
| Vision Blurred |
4.0% |
| Pruritus |
3.6% |
| Drug Exposure During Pregnancy |
3.4% |
| Renal Failure Acute |
3.4% |
| White Blood Cell Count Decreased |
3.2% |
| Pulmonary Embolism |
3.0% |
| Somnolence |
3.0% |
| Suicidal Ideation |
3.0% |
| Myocardial Infarction |
2.8% |
| Urinary Tract Infection |
2.8% |
| Vertigo |
2.8% |
|
| Interacting |
| Depression |
29.0% |
| Drug Use For Unknown Indication |
13.1% |
| Hypertension |
12.9% |
| Product Used For Unknown Indication |
6.6% |
| Major Depression |
5.8% |
| Type 2 Diabetes Mellitus |
5.1% |
| Sedation |
3.4% |
| Diabetes Mellitus |
2.7% |
| Pain |
2.7% |
| Hypothyroidism |
2.4% |
| Psychotic Disorder |
2.4% |
| Bipolar Disorder |
1.9% |
| Essential Hypertension |
1.7% |
| Glaucoma |
1.7% |
| Hyperlipidaemia |
1.7% |
| Ischaemic Heart Disease Prophylaxis |
1.7% |
| Back Pain |
1.5% |
| Lipids Increased |
1.5% |
| Anxiety |
1.2% |
| Agitation |
1.0% |
|
| Drug Interaction |
16.1% |
| Urinary Retention |
14.3% |
| Agitation |
6.3% |
| Hyponatraemia |
6.3% |
| Renal Failure Acute |
5.4% |
| Rhabdomyolysis |
5.4% |
| Serotonin Syndrome |
5.4% |
| Traumatic Haematoma |
5.4% |
| Ventricular Extrasystoles |
5.4% |
| Hepatocellular Injury |
4.5% |
| Parkinsonism |
4.5% |
| Loss Of Consciousness |
3.6% |
| Thrombophlebitis |
3.6% |
| Convulsion |
2.7% |
| Hypertensive Crisis |
2.7% |
| Eczema |
1.8% |
| Fatigue |
1.8% |
| Hepatic Failure |
1.8% |
| Hypertension |
1.8% |
| Psychiatric Symptom |
1.8% |
|
